Clinical Trials Directory

Trials / Completed

CompletedNCT03012750

Angiosome Perfusion After Tibial Bypass

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University Hospital Erlangen · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Microcirculation should be assessed before and after tibial bypass surgery by intraoperative fluorescence angiography. According to this, the direct and the indirect angiosomes should be compared according to the individual microcirculatory improvement.

Detailed description

Only patients at CLI stage Rutherford IV to VI with the necessity of tibial Bypass surgery will be included. Macrocirculation is measured by the ankle-brachial index (ABI). In order to assess the skin microcirculation intraoperative fluorescence angiography is used (SPY Elite™, NOVADAQ, Canada). The alteration of microcirculation is compared in direct and indirect revascularized angiosomes by calculation of the fluorescence parameters Ingress (IN) and Ingress rate (InR). Clinical Follow-up investigations will be performed and the wound healing rate is compared between the different revascularization methods.

Conditions

Interventions

TypeNameDescription
DRUGIndocyanine GreenPerioperative application of 0.1 mg ICG per kg Body weight

Timeline

Start date
2015-02-01
Primary completion
2016-08-01
Completion
2016-10-01
First posted
2017-01-06
Last updated
2017-01-06

Source: ClinicalTrials.gov record NCT03012750. Inclusion in this directory is not an endorsement.